[go: up one dir, main page]

WO1997032034A1 - Maitrise de la croissance d'un micro-organisme - Google Patents

Maitrise de la croissance d'un micro-organisme Download PDF

Info

Publication number
WO1997032034A1
WO1997032034A1 PCT/GB1997/000409 GB9700409W WO9732034A1 WO 1997032034 A1 WO1997032034 A1 WO 1997032034A1 GB 9700409 W GB9700409 W GB 9700409W WO 9732034 A1 WO9732034 A1 WO 9732034A1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
organism
micro
inhibitor
sphingosine
Prior art date
Application number
PCT/GB1997/000409
Other languages
English (en)
Inventor
Peter Jeremy Stephens
Original Assignee
Oxoid Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxoid Limited filed Critical Oxoid Limited
Priority to AU20055/97A priority Critical patent/AU2005597A/en
Publication of WO1997032034A1 publication Critical patent/WO1997032034A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10—Enterobacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/255—Salmonella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • This invention relates to methods for controlling micro-organism growth, and especially to methods for enriching the microorganism population of a sample prior to analysis thereof to detect the possible presence of a target organism.
  • non-target organisms can mask the presence of a target organism.
  • Previous stressful conditions such as processing of the sample material, for example pasteurisation or chemical treatment, may have injured the cells of the target organism to an extent which inhibits their ability to proliferate quickly, although they retain the capability of proliferating eventually to dangerous levels under appropriate conditions.
  • the non-target organisms can proliferate readily and, for example by competing for nutrients, so inhibit the proliferation of the injured target organism cells that it remains impossible to detect the presence of the target organism.
  • the cell division cycle inhibitor(s) should be present in a total amount which arrests or slows down cell division of at least most, preferably all, species of organisms likely to be encountered in the sample material.
  • the cell division cycle inhibitor should, of course, not be present in an amount which is toxic to the target organism, even when injured. The practical result is that cell division of potentially dominent microorganisms in the sample is delayed for a period sufficient to permit injured target microorganism cells to repair.
  • microorganism growth in the sample can be permitted, if appropriate in the presence of selective inhibitors to discourage the growth of non-target organisms,
  • the repaired target cells, if present, can compete effectively and hence proliferate satisfactorily to provide an analysis sample containing detectable levels of the target organism.
  • the invention provides a method of enriching the microorganism population of a sample, such as a foodstuff or beverage, prior to analysis thereof to detect the possible presence of a target microorganism therein, which method comprises the steps of prolonging the lag phase of the microorganism cell-division cycle of at least the majority of species present in the sample for a time sufficient to enable injured cells of the target microorganism to repair themselves, and thereafter permitting growth of microorganisms to occur in the sample.
  • the invention provides a method of enriching the microorganism population of a sample prior to analysis thereof to detect the possible presence of a target microorganism therein, in which method an inhibitor of the microorganism cell-division cycle is provided in the sample in a sub-toxic amount sufficient to prolong the lag phase of the general microorganism cell-division cycle for a time sufficient to enable cells of the target microorganism which may have been injured, for example by previous processing of the sample material, to repair themselves, and following said sufficient time growth of microorganisms present in the sample is permitted.
  • growth of microorganisms present in the sample is permitted by providing an activator of the general microorganism cell-division cycle in an amount at least sufficient to counteract any residual effect of the inhibitor.
  • one or more agents which inhibit the growth of non-target microorganisms that may be present in the sample material are added to the sample.
  • cell-division is delayed by incorporating an inhibitor of protein kinase activity in the pre-enrichment sample.
  • An inhibitor of protein kinase C activity is preferred.
  • Ideal inhibitors are sphingosines, such as D-sphingosine, analogues of sphingosines, hexadecylphosphocholine, l-0-hexadecyl-2-acetyl-rac- glycerol, l-0-hexadecyl-2-methyl-rac-glycerol and l-O-hexadecyl-2-methyl-sn-glycerol.
  • the amount of inhibitor required will depend on the nature of the sample material, the organisms likely to be present, and the effectiveness of the chosen inhibitor. In general, however, the inhibitor should be present in the culture medium, containing the sample material, in a final concentration of at least about 0.1 ⁇ M, preferably at least about 1 ⁇ M, more preferably at least about 5 ⁇ M.
  • Suitable reagents are activators of protein kinase C (or as mentioned previously, protein kinases ingeneral) include: diacylglycerols such as l-oleoyl-2- acetyl-sn-glycerol,l-oleoyl-2-acetyl-rac-glycerol,l-stearoyl-2-arachidonyl-sn-glycerol (SAG), 1,2-dihexanoyl-sn-glycerol, 1,2-dioctanoyl-rac-glycerol, 1,2-dioctanoyl-sn- glycerol, 1 ,2-didecanoyl-rac-glycerol, 1 ,2-didecanoyl-sn-glyceroland 1 ,2-dioleoyl-rac- glycerol and phorbol esters such as 12-0-tetradecanoyl-phorbol- 13 -acetate
  • a preferred reagent is l-stearoyl-2-arachidonyl-sn-glycerol (SAG).
  • SAG l-stearoyl-2-arachidonyl-sn-glycerol
  • the enrichment culture medium contains both a protein kinase inhibitor and a counteracting agent, for example a sphingosine and SAG.
  • a protein kinase inhibitor for example a sphingosine and SAG.
  • a combination of inhibitor and counteracting agent such as this enables the effect of the inhibitor in prolonging the lag phase to be modulated, thus controlling the extent of prelongation, which can be selected to best suit the nature of the sample material and the target/non- target organisms likely to occur in it.
  • the duration of the delay in the lag phase is at least about 6 hours. Generally a delay of from about 6 to about 12 hours will enable a sufficient number of injured target cells to repair.
  • the delaying effect of the cell-cycle inhibitor can wear off after an elapse of time.
  • delay can be arranged to terminate after a number of hours found by experiment to be appropriate for the target organism and typical sample material in question. This is easily built into a routine analysis procedure, for example in manufacturing control procedures, where the nature of the sample material is constant.
  • termination of the delay can be brought about by a positive action, for example dilution (e.g. by addition of sterile medium devoid of the inhibitor) and/or the addition of one or more nutrients or reagents that encourage growth, thus displacing the balance is favour of growth.
  • the invention also provides a composition for addition to sample material, or to a conventional enrichment culture medium, said composition comprising a general microorganism cell-division cycle inhibitor which, when said composition is added to sample material, causes the lag phase to be prolonged for a time sufficient to enable cells of a target microorganism which may have been injured, for example by previous processing of the sample material to repair themselves.
  • This composition can, for example, be in the form of a supplement for addition to a culture medium. This supplement is usually in the form of a small quantity of dry sterile solids, often freeze-dried.
  • a typical commercial product is a glass ampoule containing the solids, which in use is broken open and the solids are dissolved in a small quantity of sterile water, perhaps containing ethanol or the like to assist dissolution of the solids.
  • the resulting solution is added to the bulk culture medium, for example a commercially-available buffered peptone water.
  • An important embodiment of the invention is therefore an ampoule containing a cell-cycle inhibitor, preferably a sphingosine, in sterile re-hydratable form.
  • the ampoule also contains SAG.
  • a filler, such as PVP, may also be present to provide sufficient bulk for reagent handling purposes.
  • the composition additionally comprises one or more traditional agents which inhibit the growth of non-target microorganisms that may be present in the sample material.
  • Traditional selective agents that can be added include: novobiocin, sodium desoxycholate, malachite green, pH reducing agents, a w (water activity) reducing agents, brilliant green, bile salts, selenite, crystal violet and Tergitol 4.
  • the invention also provides a complete micro-organism culture medium (i.e. a medium containing nutrients) containing a cell-division cycle inhibitor in an amount sufficient to prolong the lag phase for a time sufficient to enable injured cells of a target micro-organism to repair themselves.
  • the inhibitor is preferably an inhibitor of protein kinase activity, more preferably of protein kinase C activity.
  • the inhibitor is a sphingosine, preferably in an amount of at least about O.l ⁇ M.
  • the medium additionally contains SAG, preferably in an amount of at least about O. l ⁇ M.
  • An important embodiment of the invention is a method of detecting the presence of Salmonella typ imurium in a sample likely to contain Escherichia coli, wherein during an enrichment procedure intended to encourage the establishment of a detectable Salmonella population a protein kinase activity inhibitor, especially a sphingosine, is used to prolong the lag phase of the cell-division cycle for a time sufficient to enable injured Salmonella to repair themselves and thereby to compete effectively with E.coli during the sample enrichment.
  • a protein kinase activity inhibitor especially a sphingosine
  • the invention can be applied to advantage in the analysis of a very wide range of sample materials in which the presence of micro-organisms can be of significance, for example foodstuffs, beverages, ingredients for use in such products, consumer goods such as cosmetics and personal products (e.g. toothpastes, soaps, skin cleansing/treatment compositions, shampoos), clinical samples (e.g. faeces, body fluids such as blood, serum and urine), and environmental samples (e.g. water, effluents or samples from factories or other industrial premises).
  • foodstuffs beverages
  • ingredients for use in such products for example foodstuffs, beverages, ingredients for use in such products, consumer goods such as cosmetics and personal products (e.g. toothpastes, soaps, skin cleansing/treatment compositions, shampoos), clinical samples (e.g. faeces, body fluids such as blood, serum and urine), and environmental samples (e.g. water, effluents or samples from factories or other industrial premises).
  • consumer goods such as cosmetics and personal products (e.g.
  • the invention is not limited to the detection of particular micro-organism species, but can be applied generally.
  • target organisms include Liste ⁇ a, Salmonella, Escherichia coli (for example, species producing Vero-cytotoxin), Campy lobacter, Yersinia and Vibrio species.
  • FIGS. 1 to 4 of the accompanying drawings show the results of experiments (EXAMPLE A) in which the lag phase of microorganism (Listeria monocytogenes) growth was controlled by the presence of sphingosine or combinations of sphingosine and SAG:
  • Figure 1 shows the effect on growth of various concentrations of sphingosine alone.
  • Figure 2 shows the effect on growth of combinations of 5 ⁇ M sphingosine (S) and various concentrations of SAG.
  • Figure 3 is an enlarged portion of Figure 2, covering the first 30 hours of growth only.
  • Figure 4 shows the effect on growth of combinations of 10 ⁇ M sphingosine (S) and various concentrations of SAG.
  • Figures 5 and 6 show results of experiments (EXAMPLE B) in which the lag phase of growth of heat-injured Salmonella was compared with that of fully viable £. coli.
  • Figure 5 shows the effect of various concentrations of sphingosine on the growth of heat-injured Salmonella typhimurium (10 0 3 organisms/ ml).
  • TPB tryptic phosphate broth
  • D-sphingosine (Sigma) was added to each well, from a stock solution in ethanol, to give the desired progressively varying concentration of sphingosine and an ethanol concentration that was 1 % v/v. Growth was measured using the Bioscreen, which measures increasing bacterial numbers as increasing absorbance at a light wavelength of 600nm. Growth was measured at 30°C for up to 90h. Control experiments (no sphingosine) were performed in TPB with an ethanol concentration of 1 % v/v. Experiments with both the inhibitor and the activator (SAG) were performed by adding both reagents prior to analysis in the Bioscreen thus giving an ethanol concentration of 2% v/v. The corresponding control experiment also had an ethanol concentration of 2% v/v.
  • a commonly-encountered strain of Salmonella typhimurium was cultured until the population, at about 1-5 xlO 8 organisms per ml, had reached the mid-exponential phase of growth. Approximately 10ml of this culture was heat-injured using a heating apparatus composed of a narrow bore stainless steel coil submerged in a thermostatically controlled waterbath. The coil was flushed several times with sterile distilled water and pre-heated to 53.5°C. The 10ml sample of the Salmonella culture was loaded into the coil using a disposable syringe. This pre-heating, and rapidity of loading, ensured that the total equilibration time was less than one second.
  • the culture was heated within the coil for 15 minutes.
  • the heat- injured cells were then expelled from the coil into 24 times volume of commercially-available Buffered Peptone Water (Oxoid) (hereinafter "BPW") using a second syringe. Every expulsion displaced 200 ⁇ l of culture from the coil.
  • BPW Buffered Peptone Water
  • Every expulsion displaced 200 ⁇ l of culture from the coil.
  • the first 4 or 5 ejections were discarded because these cells had been in part of the coil that projected from the waterbath and had therefore not been exposed to the correct temperature.
  • D-sphingosine (Sigma) was dissolved in absolute alcohol to give a stock solution of concentration 0.5mM. This was diluted 1 in 100 in BPW as a serial dilution to give a sphingosine concentration of 5 ⁇ M and a final ethanol concentration of 1 % .
  • a Bioscreen was used to investigate the effect of this concentration of inhibitor on the length of lag in heat- injured Salmonella typhimurium and a typical competitor organism commonly found in contaminated food samples: Escherichia coli.
  • the E.coli culture was prepared in the same manner as the Salmonella culture, but not subjected to the heat treatment.
  • sample culture was 10-fold serially diluted into either BPW and or into BPW containing the inhibitor.
  • a 100-well Bioscreen plate was set up for each sample (i.e. control and inhibited) at organism populations of about 10 2 -10 3 cells/ml.
  • the Bioscreen was programmed to measure the O.D. of every well at 600nm every 15 min for 48h.
  • the accompanying graphical drawings are based on mean O.D. readings.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Procédure améliorée d'enrichissement d'un échantillon permettant d'accroître les chances de dépistage d'organismes pathogènes, comme la salmonelle. Le procédé prévoit l'adjonction au milieu de culture d'un inhibiteur de cycle cellulaire, spécialement un inhibiteur de protéines kinase C comme de la sphingosine, sous une quantité qui prolonge la phase de décalage de la croissance du micro-organisme de plusieurs heures, soit assez pour permettre la réparation des cellules de l'organisme cible qui peuvent avoir été lésées par des conditions antérieures éprouvantes. Les cellules réparées peuvent ensuite rivaliser avec efficacité avec l'espèce non-cible dominante pouvant également être présente dans l'échantillon.
PCT/GB1997/000409 1996-02-28 1997-02-17 Maitrise de la croissance d'un micro-organisme WO1997032034A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU20055/97A AU2005597A (en) 1996-02-28 1997-02-17 Control of microorganism growth

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96301368.5 1996-02-28
EP96301368 1996-02-28

Publications (1)

Publication Number Publication Date
WO1997032034A1 true WO1997032034A1 (fr) 1997-09-04

Family

ID=8224836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000409 WO1997032034A1 (fr) 1996-02-28 1997-02-17 Maitrise de la croissance d'un micro-organisme

Country Status (2)

Country Link
AU (1) AU2005597A (fr)
WO (1) WO1997032034A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0877092A1 (fr) * 1997-04-08 1998-11-11 Becton, Dickinson and Company Détection rapide de microorganismes
WO2016210436A1 (fr) * 2015-06-26 2016-12-29 Saber Biotics, Llc Milieux sélectifs et leurs utilisations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J.E. JAMESON: "A discussion of the dynamics of Salmonella enrichment.", THE JOURNAL OF HYGIENE, vol. 60, 1962, CANBRIDGE UK, pages 193 - 207, XP000578730 *
J.J. SHERIDAN ET AL.: "The use of selective and non-selective enrichment broths for the isolation of Listeria species from meat.", FOOD MICROBIOLOGY, vol. 11, no. 5, 1994, NEW YORK NY USA, pages 439 - 446, XP000647076 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0877092A1 (fr) * 1997-04-08 1998-11-11 Becton, Dickinson and Company Détection rapide de microorganismes
WO2016210436A1 (fr) * 2015-06-26 2016-12-29 Saber Biotics, Llc Milieux sélectifs et leurs utilisations
US10752933B2 (en) 2015-06-26 2020-08-25 Saber Biotics, Llc Methods for the identification, characterization, and use of inhibitors of the fructose-asparagine utilization pathway

Also Published As

Publication number Publication date
AU2005597A (en) 1997-09-16

Similar Documents

Publication Publication Date Title
Bonnet et al. Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology
Taormina et al. Inhibitory activity of honey against foodborne pathogens as influenced by the presence of hydrogen peroxide and level of antioxidant power
Hong et al. Membrane damage and enzyme inactivation of Lactobacillus plantarum by high pressure CO2 treatment
Corry et al. Handbook of culture media for food microbiology
RU2384624C2 (ru) Способ получения образца для детектирования микроорганизма, способ детектирования микроорганизма и набор для детектирования микроорганизма
Bertoloni et al. A study on the inactivation of micro‐organisms and enzymes by high pressure CO2
Blankenship Some characteristics of acid injury and recovery of Salmonella bareilly in a model system
SK123496A3 (en) A rapid microbiological test for the detection of antibacterial compounds
CZ251094A3 (en) Unit for detecting residues of antibacterial substances in liquids
Han et al. The role of PhoP/PhoQ system in regulating stress adaptation response in Escherichia coli O157: H7
Fung et al. Repair, growth, and enterotoxigenesis of Staphylococcus aureus S-6 injured by freeze-drying
WO1997032034A1 (fr) Maitrise de la croissance d'un micro-organisme
Liao et al. Growth dynamics of Clostridium perfringens superdormant spores in cooked ground pork under synergic treatment of heat and hydrostatic pressure
Chase et al. The Role of Penicillin‐Binding Proteins in the Action of Cephalosporins against Escherichia coli and Salmonella typhimurium
US4766063A (en) Process and device for detecting the activity of a substance on a micro-organism or on a mixture of micro-organisms
WO1999002650A1 (fr) Enrichissement selectif et detection de micro-organismes
EP1216307B2 (fr) Procede de detection de residus antimicrobiens
Sveum et al. Recovery of salmonellae from foods using a combined enrichment technique
US20200270670A1 (en) Culture medium for selectively isolating bacteria of genus clostridium
WO2001025795A2 (fr) Detection de residus antimicrobiens dans les oeufs
Zayaitz et al. Characteristics of acid-injury and recovery of Staphylococcus aureus in a model system
PALUMBO A REVIEW OF METHODS FOR DETECTION OF THE PSYCHROTROPHIC FOODBORNE PATHOGENS LISTERIA MONOCYTOGENES AND AEROMONAS HYDROPHILA 1
Everis Injured bacteria in foods
Sharpe Development and evaluation of membrane filtration techniques in microbial analysis
EP4464790A1 (fr) Outil moléculaire pour la détection rapide d'agents pathogènes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97530687

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA